Inventor
TAISHI TERUHIKO
JP10 patents
⚠️ This page may combine multiple inventors who share the name “TAISHI TERUHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIONOGI & CO
7 patentsUS8778943B2Jul 15, 2014
Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-α]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides
SHIONOGI & CO30 citations95
US9051337B2Jun 9, 2015
Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides
SHIONOGI & CO27 citations92
US10927129B2Feb 23, 2021
N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity
SHIONOGI & CO3 citations83
US9273065B2Mar 1, 2016
Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors
SHIONOGI & CO3 citations83
US7358249B2Apr 15, 2008
Heterocyclic compounds having inhibitory activity against HIV integrase
SHIONOGI & CO8 citations73
US11267823B2Mar 8, 2022
Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity
SHIONOGI & CO2 citations72
US7919623B2Apr 5, 2011
Naphthyridine derivatives having inhibitory activity against HIV integrase
SHIONOGI & CO0 citations41
JOHNS BRIAN ALVIN
2 patentsUS8129385B2Mar 6, 2012
Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness
JOHNS BRIAN ALVIN66 citations97
US8410103B2Apr 2, 2013
(3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agent
JOHNS BRIAN ALVIN33 citations95